Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

CUSIP: 14161W105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
53,041,500
Total 13F shares
31,402,934
Share change
+920,086
Total reported value
$3,990,653,437
Put/Call ratio
72%
Price per share
$126.93
Number of holders
189
Value change
+$126,270,154
Number of buys
95
Number of sells
112

Quarterly Holders Quick Answers

What is CUSIP 14161W105?
CUSIP 14161W105 identifies CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2021

As of 30 Jun 2021, Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by 189 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,402,934 shares. The largest 10 holders included CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Alua Capital Management LP, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, MORGAN STANLEY, and Antipodean Advisors LLC. This page lists 189 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.